32 /100
MEDIUM RISK
Score updated May 30, 2026

DMAC — DiaMedica Therapeutics Inc. Dilution Risk Tracker

Track DMAC dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track DMAC — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
10
📊 Float Risk
45
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
7%
📉 Score Deterioration 15%
• Score climbed 8 points (worsening)
🔔 Track DMAC — Get forecast alerts →

💹 Market Data

Market Cap$322.76M
Shares Outstanding53.88M
Float28.60M
Cash$51.33M
Debt$212.0K
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 6.4% shares (2025Q4 vs prior)
94 institutional holders · 12.37M shares
#1 COOPERMAN LEON G 2.02M shares
#2 BlackRock, Inc. 1.90M shares
#3 PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE 875.0K shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest4.84M
Days to Cover27.4
% of Float16.9%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2018
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track DMAC Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking DMAC — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for DMAC
📊 DMAC FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 DMAC Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.